Personalized Medicine Market 2011

Language:
Japanese
Product Code No:
C53100830
Issued In:
2011/01
#of Pages:
223
Publication Cycle:
Other
Format:
PDF

Price

300,000 yen ($2,748.51)
(excluding consumption tax)
600,000 yen ($5,497.02)
(excluding consumption tax)
900,000 yen ($8,245.53)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 109.15 yen , 2020/04/07 Japan)

Coverage: (Product/service)

Personalized medicine, tailor-made medicine, custom-made medicine, made-to-order medicine

Research Target:

Manufacturers and clinical laboratories

Research Content:

 

A. INDUSTRY OVERVIEW
1. Current trends and market issues
2. Player and product trends
3. Market size (FY 2009 to FY 2011 forecast) and market share (FY 2010 estimate)
4. R&D trends
5. Project trends
6. Laws and regulations
7. Distribution structure
8. Future outlook
 
B. MARKET ANALYSIS
Market trends, market issues, player trends, product trends, market size, market share, R&D trends, sales and marketing trends, distribution structure and future outlook by:
1. Molecular targeting drug
2. Genetic diagnostic reagent
3. DNA chip
4. Genetic testing (contract clinical research)
5. Next-generation DNA sequencer
 
C. COMPANY TRENDS
[Pharmaceutical Companies]
Astellas Pharma, Kyowa Hakko Kirin, Daiichi Sankyo, Takeda Pharmaceutical, Chugai Pharmaceutical
[Clinical Diagnostic Reagent and Device Manufacturers]
Eiken Chemical, Qiagen, Sekisui Medical, Dako Japan, Toyobo, Roche Diagnostics
[DNA Chip and Bio-research Reagent and Device Manufacturers]
Affymetrix, DNA Chip Research, Riken Genesis
[Clinical Laboratories and Centers]
SRL, Mitsubishi Chemical Medience, BML, FalcoSD Holdings
[Next-generation DNA Sequencer Manufacturers]
Illumina, Life Technologies

Price

written in Japanese
300,000 yen ($2,748.51)
(excluding consumption tax)
600,000 yen ($5,497.02)
(excluding consumption tax)
900,000 yen ($8,245.53)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 109.15 yen , 2020/04/07 Japan)